Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
Sponsor: Tanta University
Summary
The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury
Official title: Role of Non-Selective Beta-Adrenergic Blocker in Severe Traumatic Brain Injury
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-09-20
Completion Date
2025-09-20
Last Updated
2025-03-11
Healthy Volunteers
No
Interventions
propranolol
This group Will receive propranolol intravenously at a dose of 1 mg every 6 h for 7 days, and doses will be held if heart rate less than 60 bpm, mean arterial pressure less than 65 mmHg
normal saline IV
This group Will receive 1ml of sterile 0.9% normal saline IV every 6 hours for 7 days
Locations (1)
Tanta University
Tanta, Egypt